C
Context Therapeutics D
D
CNTX
2.21500
USD
0.03
(1.14%)
مغلق
حجم التداول
1,639
الربح لكل سهم
0
العائد الربحي
0
P/E
-2
حجم السوق
166,121,261
العنوان: Context Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.